| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8963421 | Sleep Medicine Reviews | 2018 | 31 Pages |
Abstract
Presynaptic dopaminergic neuroimaging may be a key feature in the stratification of subjects to be included in neuroprotective trials. However, literature data are heterogeneous. Multicentric, harmonized studies are needed to define the usefulness of presynaptic dopaminergic neuroimaging with the aim of testing neuroprotective trials for idiopathic RBD.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Matteo Bauckneht, Andrea Chincarini, Fabrizio De Carli, Michele Terzaghi, Silvia Morbelli, Flavio Nobili, Dario Arnaldi,